Norges Bank
SNDX icon

Norges Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Norges Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-169,100
Closed -$4.3M – 2158
2022
Q4 		$4.3M Sell
169,100
-19,100
-10% -$445K ﹤0.01% 1818
2022
Q3 		$4.52M Buy
+188,200
New +$4.22M ﹤0.01% 1788
2022
Q2 		– Sell
-484,900
Closed -$8.43M – 2159
2022
Q1 		$8.43M Hold
484,900
– – ﹤0.01% 1756
2021
Q4 		$10.6M Buy
+484,900
New +$8.96M ﹤0.01% 1740
2016
Q3 		– Sell
-24,768
Closed -$244K – 2170
2016
Q2 		$244K Sell
24,768
-232
-0.9% -$3.18K ﹤0.01% 2149
2016
Q1 		$333K Buy
+25,000
New +$314K ﹤0.01% 2150

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Norges Bank's SNDX Position: Q1 2023 in Review

Norges Bank sold out of Syndax Pharmaceuticals (SNDX) in Q1 2023, closing a stake of 169,100 shares — an estimated $4.3M sold.

Norges Bank first reported a position in SNDX in Q1 2016 and held it in 6 quarters. The position peaked at $10.6M in Q4 2021. 163 funds tracked by Wall St. Rank hold SNDX as of Q1 2023.

  • Norges Bank reported no remaining Syndax Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Norges Bank sold 169,100 Syndax Pharmaceuticals shares in Q1 2023, an estimated $4.3M.
  • Norges Bank first reported a position in Syndax Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Norges Bank's Syndax Pharmaceuticals position peaked at $10.6M in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2023.

Based on Norges Bank's 13F filing for Q1 2023, filed 15 May 2023.